Skip to content

A multicenter, randomized controlled clinical study on the effectiveness and safety of splenic artery ligation in reducing postoperative complications during liver transplantation

A multicenter, randomized controlled clinical study on the effectiveness and safety of splenic artery ligation in reducing postoperative complications during liver transplantation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089229
Enrollment
Unknown
Registered
2024-09-04
Start date
2025-10-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end-stage liver disease with splenomegaly

Interventions

Control group:Routine liver transplantation surgery
Experimental group:Routine liver transplantation surgery with intraoperative splenic artery ligation

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.end-stage liver disease meet criterion of liver transplantation; 2.sign informed consent independently; 3.splenomegaly (>Five intercostal Spaces in CT scan).

Exclusion criteria

Exclusion criteria: 1. The recipient's hepatic artery and splenic artery are not from a common trunk; 2. The splenic artery cannot be dissected or freed; 3. Poor hepatic artery condition (weak fluctuation after arterial anastomosis (right hepatic artery flow rate 10 hours); 5. Split or reduced-size liver transplantation; 6. Recipient with expected survival not exceeding 6 months; 7. HIV or acute tuberculosis infection; 8. Recipient requiring biliary-enteric anastomosis; 9. Previous liver transplantation or requiring combined transplantation.

Design outcomes

Primary

MeasureTime frame
Non-anastomotic biliary stricture;

Secondary

MeasureTime frame
Abdominal infection;ICU duration and in-hospital duration after transplantation;Postoperative complications;Vascular complications;Early allograft dysfunction;Blood flow changes in the hepatic artery and portal vein main trunks before and after splenic artery ligation;Platelet improvement;Surgical duration;Splenic abscess;1-year and 3-year survival rates;NAS or death within 6 months after liver transplantation;Sepsis;primary non-function;new onset diabetes after transplantation, NODAT;anastomotic biliary strictures,AS;The severity of NAS;highest total bilirubin and INR 7 days after transplantation;pancreatitis;bile leakage;Onset time of NAS;splenic artery aneurysm;highest ALT and AST 7 days after transplantation;

Countries

China

Contacts

Public ContactLeida Zhang

The First Affiliated Hospital of Army Medical University

zldxngd@163.com+86 23 65460505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026